Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine
出版年份 2009 全文链接
标题
Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine
作者
关键词
-
出版物
JOURNAL OF LEUKOCYTE BIOLOGY
Volume 86, Issue 4, Pages 779-793
出版商
Wiley
发表日期
2009-07-14
DOI
10.1189/jlb.0209094
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques
- (2009) Vincent Vieillard et al. AIDS
- HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers
- (2009) Taha Hirbod et al. AIDS
- A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C Adeno-Associated Virus Vaccine
- (2009) Sanjay Mehendale et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Preclinical and Clinical Development of a Multi-Envelope, DNA-Virus-Protein (D-V-P) HIV-1 Vaccine
- (2009) Robert Sealy et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Design, Construction, and Characterization of a Multigenic Modified Vaccinia Ankara Candidate Vaccine Against Human Immunodeficiency Virus Type 1 Subtype C/B′
- (2009) Zhiwei Chen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- AIDS pathogenesis: a tale of two monkeys
- (2009) Guido Silvestri JOURNAL OF MEDICAL PRIMATOLOGY
- Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
- (2009) Scott G Hansen et al. NATURE MEDICINE
- Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses
- (2009) Matthias Liniger et al. VACCINE
- Novel SIVmac DNA vaccines encoding Env, Pol and Gag consensus proteins elicit strong cellular immune responses in cynomolgus macaques
- (2009) Jian Yan et al. VACCINE
- Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160ΔV1V2 is strongly immunogenic
- (2009) Mathilde Guerbois et al. VIROLOGY
- Post-Step modifications for research on HIV vaccines
- (2008) Lawrence Corey et al. AIDS
- Emerging Concepts in the Immunopathogenesis of AIDS
- (2008) Daniel C. Douek et al. Annual Review of Medicine
- Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFNγ response, even at three years after immunization
- (2008) Mamoru Kawahara CLINICAL IMMUNOLOGY
- Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults
- (2008) Frances H. Priddy et al. CLINICAL INFECTIOUS DISEASES
- Elite control of HIV infection: implications for vaccine design
- (2008) BM Baker et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Broad Immunogenicity of a Multigene, Multiclade HIV‐1 DNA Vaccine Boosted with Heterologous HIV‐1 Recombinant Modified Vaccinia Virus Ankara
- (2008) Eric Sandström et al. JOURNAL OF INFECTIOUS DISEASES
- Genetic and Immunologic Heterogeneity among Persons Who Control HIV Infection in the Absence of Therapy
- (2008) Florencia Pereyra et al. JOURNAL OF INFECTIOUS DISEASES
- Immunity in natural SIV infections
- (2008) G. Silvestri JOURNAL OF INTERNAL MEDICINE
- Gag-Specific Cytotoxic T-Lymphocyte-Based Control of Primary Simian Immunodeficiency Virus Replication in a Vaccine Trial
- (2008) M. Kawada et al. JOURNAL OF VIROLOGY
- Sequential Priming with Simian Immunodeficiency Virus (SIV) DNA Vaccines, with or without Encoded Cytokines, and a Replicating Adenovirus-SIV Recombinant Followed by Protein Boosting Does Not Control a Pathogenic SIVmac251 Mucosal Challenge
- (2008) T. Demberg et al. JOURNAL OF VIROLOGY
- Vaccine Protection by Live, Attenuated Simian Immunodeficiency Virus in the Absence of High-Titer Antibody Responses and High-Frequency Cellular Immune Responses Measurable in the Periphery
- (2008) K. Mansfield et al. JOURNAL OF VIROLOGY
- HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control
- (2008) B. Emu et al. JOURNAL OF VIROLOGY
- HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition
- (2008) T. Miura et al. JOURNAL OF VIROLOGY
- Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys
- (2008) J. Liu et al. JOURNAL OF VIROLOGY
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
- (2008) M Juliana McElrath et al. LANCET
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
- Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
- (2008) Jinyan Liu et al. NATURE
- HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells
- (2008) James Arthos et al. NATURE IMMUNOLOGY
- A Recoding Method to Improve the Humoral Immune Response to an HIV DNA Vaccine
- (2008) Yaoxing Huang et al. PLoS One
- Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B
- (2008) Shuangqing Yu et al. VACCINE
- Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses
- (2008) Shakuntala Megati et al. VACCINE
- Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers
- (2008) A. Guimarães-Walker et al. VACCINE
- Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation
- (2008) Margherita Rosati et al. VACCINE
- Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines
- (2008) Rong Xu et al. VACCINE
- EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
- (2008) Sheena McCormack et al. VACCINE
- Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers
- (2008) Shixia Wang et al. VACCINE
- Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa
- (2008) Walter Jaoko et al. VACCINE
- The safety and tolerability of an HIV-1 DNA prime–protein boost vaccine (DP6-001) in healthy adult volunteers
- (2008) Jeffrey S. Kennedy et al. VACCINE
- AIDSVAX immunization induces HIV-specific CD8+ T-cell responses in high-risk, HIV-negative volunteers who subsequently acquire HIV infection
- (2008) Norman G. Jones et al. VACCINE
- Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses
- (2008) Andreas Bråve et al. VACCINE
- HIV-1 T-cell vaccines: evaluating the next step
- (2007) Giuseppe Pantaleo LANCET INFECTIOUS DISEASES
- Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus
- (2007) Frédéric Martinon et al. VACCINE
- Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques
- (2007) Lauren A. Hirao et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started